The STEP 1 trial showed semaglutide 2.4 mg led to 14.9% weight loss over 68 weeks, while SURMOUNT-1 showed tirzepatide achieved up to 20.9% weight reductionapproaching bariatric surgery outcomes.[6] The SELECT trial (17,604 patients) found semaglutide reduced cardiovascular death, non-fatal heart attack, and non-fatal stroke by 20% and all-cause mortality by 19%, suggesting direct cardioprotective effects beyond weight loss.[4] In STEP-HFpEF, semaglutide produced 13.3% weight loss in heart failure patients and improved symptoms and physical function
Together they cover the energy and defence sides of cellular longevity
Dworak A, Nykiel M, Walczak B et al (2016) Maize proteomic responses to separate or overlapping soil drought and two-spotted spider mite stresses
References Journal of Pharmacological Sciences Klicek R et al
Enhance GLP-1 Results with LiftEX Removes loose skin left behind after GLP-1 weight loss No general anesthesia or overnight stay required Customized for common areas: stomach, arms, thighs, and more Minimally invasive for faster healing and visible results Sculpt Your Shape Your Body, One Visit Away LiftEX helps remove sagging skin and tighten your shape after GLP-1 weight loss, all in a single, awake procedure